Latest article
The world’s first-in-class miRNA therapeutics to treatment diabetes by pancreatic beta cell regeneration
While RNA vaccine development has been in the spotlight since the Corona-19 outbreak, RSVI-301, RosVivo’s new drug pipeline for diabetes, also uses miRNA (micro-RNA)....
